Study of Treatment of Lisfranc Injuries

NCT02953067 · Status: TERMINATED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 69

Last updated 2023-11-13

No results posted yet for this study

Summary

This trial is designed to compare different treatments on Lisfranc fractures. The trial consist of 2 different strata. Stratum 1: In mild injuries the comparison is between conservative treatment and operative treatment with open reduction and internal fixation (ORIF). Stratum 2: In severe injuries the comparison is between operative treatment with open reduction and internal fixation (ORIF) and primary arthrodesis. The primary outcome measure will be AOFAS Midfoot Score, and secondary outcome measure will be VAS Foot and Ankle.

Conditions

  • Foot Injury

Interventions

PROCEDURE

Open reduction and internal fixation

Stratum 1: Conservative treatment versus open reduction and internal fixation Stratum 2: Open reduction and internal fixation versus arthrodesis

PROCEDURE

Primary arthrodesis

Primary arthrodesis versus ORIF

PROCEDURE

Conservative treatment

Conservative treatment versus open reduction and internal fixation

Sponsors & Collaborators

  • Seinajoki Central Hospital

    collaborator OTHER
  • Tampere University Hospital

    lead OTHER

Principal Investigators

  • Heikki-Jussi Laine, MD; PhD · Tampere University

  • Tiina Kaistila, MS · Tampere University

  • Ville Mattila, Professor · Tampere University

  • Antti Paakkala, MD;PhD · Tampere University

  • Heikki Mäenpää, Docent · Tampere University

  • Mikko Kirjavainen, MD; PhD · Dextra Fertility Clinic

  • Janne Jousmäki, MD · Seinajoki Central Hospital

  • Olli Väistö, MD; PhD · Seinajoki Central Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
60 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2012-03-31
Primary Completion
2023-08-31
Completion
2023-08-31

Countries

  • Finland

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02953067 on ClinicalTrials.gov